Trial Profile
A Phase I, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Multiple Intravenous Administration of YC-6 in Healthy Chinese Adult Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2019
Price :
$35
*
At a glance
- Drugs Androtriol (Primary)
- Indications Stroke
- Focus Adverse reactions
- Sponsors Guangzhou Cellprotek Pharmaceutical
- 07 Dec 2017 New trial record